Potential of placenta-derived mesenchymal stem cells as seed cells for bone tissue engineering: Preliminary study of osteoblastic differentiation and immunogenicity

Orthopedics

Volumn 35, Issue 9, 2012, Pages 779-788

  Zhong, Zhi Nian ^a   Zhu, Shao Fang ^b   Yuan, Ai Dong ^a   Lu, Guo Hui ^c   He, Zheng Yan ^a   Fa, Zhi Qiang ^c   Li, Wen Hu ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b SHAOGUAN UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD133 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; SCATTER FACTOR; SOMATOMEDIN C; THY 1 ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL LABELING; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOBLAST; PROTEIN SECRETION; RAT; TISSUE DIFFERENTIATION; TISSUE ENGINEERING; TISSUE INDUCTION; TRANSMISSION ELECTRON MICROSCOPY;

BATCH CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEASIBILITY STUDIES; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOGENESIS; PILOT PROJECTS; PLACENTA; PREGNANCY; TISSUE ENGINEERING;

EID: 84866275084     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20120822-07     Document Type: Article

References (44)

1. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002; 84(3):454-464. (Pubitemid 37107720)
2. Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater. 2008; 15:100-114. (Pubitemid 351955734)
3. Zomorodian E, Baghaban Eslaminejad M. Mesenchymal stem cells as a potent cell source for bone regeneration. Stem Cells Int. 2012; 2012:980353.
4. Perry CR. Bone repair techniques, bone graft, and bone graft substitutes. Clin Orthop Relat Res. 1999; (360):71-86. (Pubitemid 29140936)
5. Oppenheim JS, Segal DH, Spitzer DE. Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery. 2002; 51(3):854-855. (Pubitemid 36331090)
6. Neman J, Hambrecht A, Cadry C, Jandial R. Stem cell-mediated osteogenesis: therapeutic potential for bone tissue engineering. Biologics. 2012; 6:47-57.
7. Ni P, Fu S, Fan M, et al. Preparation of poly(ethylene glycol)/polylactide hybrid fibrous scaffolds for bone tissue engineering. Int J Nanomedicine. 2011; 6:3065-3075.
8. Rahaman MN, Day DE, Bal BS, et al. Bioactive glass in tissue engineering. Acta Biomater. 2011; 7(6):2355-2373.
9. Cai YZ, Wang LL, Cai HX, et al. Electrospun nanofibrous matrix improves the regeneration of dense cortical bone. J Biomed Mater Res A. 2010; 95(1):49-57.
10. Wang L, Zou D, Zhang S, et al. Repair of bone defects around dental implants with bone morphogenetic protein/fibroblast growth factor-loaded porous calcium phosphate cement: a pilot study in a canine model. Clin Oral Implants Res. 2011; 22(2):173-181.
11. Rebelatto CK, Aguiar AM, Moretão MP, et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med. 2008; 233(7):901-913.
12. Panepucci RA, Siufi JL, Silva WA Jr, et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells. 2004; 22(7):1263-1278. (Pubitemid 39646504)
13. Shih DT, Lee DC, Chen SC, et al. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells. 2005; 23(7):1012-1020. (Pubitemid 41170957)
14. Hoffman LM, Carpenter MK. Characterization and culture of human embryonic stem cells. Nat Biotechnol. 2005; 23(6):699-708. (Pubitemid 41716360)
15. Rosland GV, Svendsen A, Torsvik A, et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009; 69(13):5331-5339.
16. Izadpanah R, Kaushal D, Kriedt C, et al. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res. 2008; 68(11):4229-4238.
17. Draper JS, Smith K, Gokhale P, et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol. 2004; 22(1):53-54. (Pubitemid 38057956)
18. Maitra A, Arking DE, Shivapurkar N, et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet. 2005; 37(10):1099-1103. (Pubitemid 41486662)
19. Fukuchi Y, Nakajima H, Sugiyama D, et al. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells. 2004; 22(5):649-658. (Pubitemid 39166923)
20. Xiong N, Zhang Z, Huang J, et al. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Ther. 2011; 18(4):394-402.
21. Fasouliotis SJ, Schenker JG. Human umbilical cord blood banking and transplantation: a state of the art. Eur J Obstet Gynecol Reprod Biol. 2000; 90(1):13-25. (Pubitemid 30190195)
22. Lee JM, Jung J, Lee HJ, Cho KJ, Hwang SG, Kim GJ. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol. 2012; 13(2):219-224.
23. Kim MJ, Shin KS, Jeon JH, et al. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells. Cell Tissue Res. 2011; 346(1):53-64.
24. Fazekasova H, Lechler R, Langford K, Lombardi G. Placenta-derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCs. J Tissue Eng Regen Med. 2011; 5(9):684-694.
25. Hayati AR, Mohamed AE, Tan GC. An immunohistochemical study of Toll-like receptors 2 and 4 in placenta with and without infection. Malays J Pathol. 2010; 32(1):13-19.
26. Beer AE, Sio JO. Placenta as an immunological barrier. Biol Reprod. 1982; 26(1):15-27. (Pubitemid 12130606)
27. Flynn A, Finke JH, Loftus MA. Comparison of interleukin 1 production by adherent cells and tissue pieces from human placenta. Immunopharmacology. 1985; 9(1):19-26. (Pubitemid 15000648)
28. Mortimer RH, Landers KA, Balakrishnan B, et al. Secretion and transfer of the thyroid hormone binding protein transthyretin by human placenta. Placenta. 2012; 33(4):252-256.
29. Sahraravand M, Järvelä IY, Laitinen P, Tekay AH, Ryynänen M. The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of pregnancy. Placenta. 2011; 32(12):999-1003.
30. Huang YC, Yang ZM, Chen XH, et al. Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev. 2009; 5(3):247-255.
31. Parolini O, Alviano F, Bagnara GP, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells. 2008; 26(2):300-311.
32. Rebelatto CK, Aguiar AM, Moretao MP, et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med. 2008; 233(7):901-913.
33. Battula VL, Bareiss PM, Treml S, et al. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation. 2007; 75(4):279-291. (Pubitemid 46434949)
34. Buttery LD, Bourne S, Xynos JD, et al. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng. 2001; 7(1):89-99. (Pubitemid 32175965)
35. Rosland GV, Svendsen A, Torsvik A, et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 2009; 69(13):5331-5339.
36. Grellier M, Ferreira-Tojais N, Bourget C, Bareille R, Guillemot F, Amedee J. Role of vascular endothelial growth factor in the communication between human osteoprogenitors and endothelial cells. J Cell Biochem. 2009; 106(3):390-398.
37. D'Ippolito G, Schiller PC, Perez-stable C, et al. Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone. 2002; 31(2):269-275. (Pubitemid 34814960)
38. Hossain M, Irwin R, Baumann MJ, McCabe LR. Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces. Biomaterials. 2005; 26(15):2595-2602. (Pubitemid 39600711)
39. Chua KH, Aminuddin BS, Fuzina NH, Ruszymah BH. Interaction between insulin-like growth factor-1 with other growth factors in serum depleted culture medium for human cartilage engineering. Med J Malaysia. 2004; 59(suppl B):7-8.
40. Barros MM, Yamamoto M, Figueiredo MS, et al. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia. Transfusion. 2009; 49(1):154-160.
41. Tournamille C, Blancher A, Le Van Kim C, et al. Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines. Immunogenetics. 2004; 55(10):682-694. (Pubitemid 38221668)
42. Fonseca AM, Pereira CF, Porto G, Arosa FA. Red blood cells promote survival and cell cycle progression of human peripheral blood T cells independently of CD58/LFA-3 and heme compounds. Cell Immunol. 2003; 224(1):17-28. (Pubitemid 37315577)
43. Czapiga M, Kirk AD, Lekstrom-Himes J. Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation. Exp Hematol. 2004; 32(2):135-139. (Pubitemid 38177638)
44. Meabed MH, Taha GM, Mohamed SO, El-Hadidy KS. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes. Hematology. 2007; 12(4):301-307. (Pubitemid 47180656)